news

Although great efforts in understanding the mechanisms underlying acute myeloid leukaemia (AML) have resulted in better diagnosis of the disease, attempts to improve its current treatment — a regimen combining cytarabine and anthracycline, that has been standard of car…   READ MORE

A multi-institutional academic and industry research team led by investigators from Massachusetts General Hospital (MGH) and the Harvard Stem Cell Institute has identified a promising new…   READ MORE

Researchers at Massachusetts General Hospital (MGH) and the Harvard Stem Cell Institute (HSCI) have identified a drug compound that arrests in mice the progression of acute myeloid leukemia (AML), a bone marrow cancer that has not seen a new therapy in four decades…   READ MORE